Bamocaftor

CAS No. 2204245-48-5

Bamocaftor( —— )

Catalog No. M34520 CAS No. 2204245-48-5

Bamocaftor is a CFTR channel (DeltaF508-CFTR mutation) corrector for CF transmembrane conductance regulators designed to restore F508del-CFTR protein function.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 1226 In Stock
5MG 847 In Stock
10MG 1159 In Stock
25MG 1701 In Stock
50MG 2260 In Stock
100MG 3050 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bamocaftor
  • Note
    Research use only, not for human use.
  • Brief Description
    Bamocaftor is a CFTR channel (DeltaF508-CFTR mutation) corrector for CF transmembrane conductance regulators designed to restore F508del-CFTR protein function.
  • Description
    Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508del-CFTR protein function. Bamocaftor can be used combine with Tezacaftor (HY-15448) and Ivacaftor (HY-13017) in cystic fibrosis research.
  • In Vitro
    Bamocaftor is a CFTR corrector designed to restore F508del-CFTR protein function.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    CFTR
  • Recptor
    CFTR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2204245-48-5
  • Formula Weight
    591.65
  • Molecular Formula
    C28H32F3N5O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (169.02 mM; Ultrasonic (<60°C)
  • SMILES
    C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ghelani DP, et al. Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation.?
molnova catalog
related products
  • Nesolicaftor

    PTI-428 specifically enhances cystic fibrosis transmembrane conductance regulator protein synthesis.

  • FDL169

    FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients who carry the F508del mutation.

  • Icenticaftor

    Icenticaftor is an orally active potentiator of?CFTR channel.